Equity Research Asset Management

Should You Buy BlackRock Science and Technology Term Trust Stock in 2026?

By CirclFi Research Team · · Updated · 1/13 models active

According to the CirclFi Deep Alpha Valuation Engine, BlackRock Science and Technology Term Trust (BSTZ) sits in the bottom tier of our quality coverage with a score of 2.2/10. While a weak quality score suggests operational challenges, our valuation models assess if the market has over-discounted the stock at $27.81.

The short answer: 0 of 1 CirclFi valuation models project upside for BlackRock Science and Technology Term Trust (BSTZ) at $27.81 — the model consensus leans bearish, with a Quality Score of 2.2/10 and Value-Trap risk of 0/100. The full bull case, bear case, and risk factors are below. Educational analysis, not financial advice.

Key Takeaways

  • 1 of 1 models suggest overvaluation — majority bearish
  • Quality Score: 2.2/10 — Very Weak — significant concerns
  • Value Trap Risk: 0/100 — Minimal — healthy fundamentals
  • Fair Value Range: $16.41 – $16.41 (0% spread)

Bullish Models

0 / 1

Bearish Models

1 / 1

Quality Score

2.2 /10

Very Weak — significant concerns

Value Trap Risk

0 /100
Minimal

Minimal — healthy fundamentals

Model Consensus

1 /13
Active Models

Avg. confidence: 7%

What Is the Investment Case for BlackRock Science and Technology Term Trust (BSTZ) in 2026?

What Is the Bull Case vs the Bear Case for BlackRock Science and Technology Term Trust (BSTZ)?

Bull case versus bear case for BlackRock Science and Technology Term Trust (BSTZ) at $27.81, derived from 1 active CirclFi valuation models on 2026-09-15.
Bull case Bear case — $16.41 target (-41.0%)
No active model projects meaningful upside for BSTZ at $27.81. Bulls would have to argue that qualitative factors the models cannot measure will unlock value. According to the CirclFi Quality of Company (QOC) framework, BlackRock Science and Technology Term Trust's rating of 2.2/10 indicates below-average quality, raising questions about sustainable earnings levels.
According to the CirclFi Deep Alpha Valuation Engine, the Markov DDM model sees the stock as overvalued with a fair value of $16.41 (-41.0%), suggesting that the market price embeds overly optimistic growth assumptions.

How Does BSTZ Compare to Its Asset Management Peers?

IGI Western Asset Invest
2.2
ECAT BlackRock ESG Capita
2.2
RGT Royce Global Trust,
2.2
BUI BlackRock Utilities,
2.2
CPZ Calamos Long/Short E
2.2
BIT BlackRock Multi-Sect
2.2
NSLR Neostellar Capital C
7.4
ASST Strive, Inc.
6.0

Valuation data pages: IGI · ECAT · RGT · BUI · CPZ · BIT · NSLR · ASST · BOE · HLNE · AMP

See full Asset Management rankings →

Which Other Stocks Score Like BSTZ on Quality?

Closest companies to BSTZ’s Quality of Company score of 2.2/10, across all industries.

Why Do CirclFi’s 1 Models Disagree on BSTZ?

Spread

0%

Fair Value Range

$16.41 – $16.41

A tight 0% spread suggests meaningful convergence, strengthening conviction in the composite estimate.

Most Bullish

Markov DDM

$16.41 (-41.0%)

Most Bearish

Markov DDM

$16.41 (-41.0%)

What Are the Biggest Risks of Buying BSTZ Stock?

Weak Fundamentals

QOC 2.2/10 signals below-average quality.

Bearish Consensus

1/1 models suggest overvaluation.

Macro/Sector Risk

Asset Management headwinds could affect earnings trajectory.

Model Limitations

Backward-looking models cannot predict disruptions.

Want the full 13-model breakdown?

See every fair value, confidence score, and value trap analysis.

View BSTZ Data Page →

So Is BlackRock Science and Technology Term Trust (BSTZ) Worth Buying in 2026?

Our valuation engine sends a clear cautionary signal on BlackRock Science and Technology Term Trust at $27.81. 1/1 models flag overvaluation, median fair value sits at $16.41 (-41.0%), and the risk-reward profile appears unfavorable. Quality at 2.2/10 adds to the concern. This is a stock where patience — or avoidance — may be the optimal strategy.

These are quantitative model outputs, not investment recommendations. BlackRock Science and Technology Term Trust's future depends on factors — management execution, competitive dynamics, regulatory changes — that no algorithm can fully capture. See all 13 model estimates →

What Else Do Investors Ask About BSTZ Stock?

Should I buy BSTZ stock right now?

Based on CirclFi's multi-model analysis, 0 of 1 models see upside for BSTZ at $27.81. No active models currently project upside, suggesting the market price may already reflect or exceed fair value. This is not a buy recommendation — see our full disclaimer.

What are the biggest risks of investing in BlackRock Science and Technology Term Trust?

Key risks include: a below-average Quality Score of 2.2/10, indicating fundamental weakness; limited model coverage (1/13 active), reducing analytical confidence; general market and sector-specific risks affecting Asset Management companies. Always diversify and consult a financial advisor.

How does BSTZ compare to its competitors?

Among Asset Management peers, BSTZ holds a Quality Score of 2.2/10. Comparable companies include IGI (QOC 2.2), ECAT (QOC 2.2), RGT (QOC 2.2). The relative ranking helps investors identify whether BSTZ offers better fundamental quality than alternatives in the same sector.

Is BSTZ a good long-term investment?

Long-term investment potential depends on fundamental quality and sustainable competitive advantages. BSTZ's Quality Score of 2.2/10 raises concerns about long-term viability without significant operational improvements. Check our full data page for all 13 model estimates.

What price should I buy BSTZ at?

CirclFi does not provide target buy prices or price alerts. However, our 1 active models produce fair value estimates ranging from $16.41 to $16.41. At $27.81, the stock trades above all model estimates. Many value investors look for a 20-30% margin of safety below intrinsic value before buying.

Want the complete picture?

See all 13 model estimates, confidence scores, and the full valuation table for BSTZ.

View BSTZ Data Page Full Terminal — $39/mo

Disclaimer: This article is produced by the CirclFi Valuation Engine using quantitative models and is for educational and informational purposes only. It is not financial advice, a buy/sell recommendation, or a solicitation to trade securities. Past performance is not indicative of future results. All data sourced from SEC EDGAR, FRED, and GDELT. Consult a licensed financial advisor before making investment decisions. Full disclaimer →